COVID-19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

被引:3
|
作者
Declercq, Jozefien [1 ,2 ,3 ]
Tobback, Els [4 ]
Vanhee, Stijn [2 ,3 ]
De Ruyck, Natalie [1 ]
Gerlo, Sarah [5 ,6 ]
Gevaert, Philippe [1 ]
Vandekerckhove, Linos [3 ,4 ,5 ]
机构
[1] Univ Ghent, Upper Airways Res Lab URL, Dept Otorhinolaryngol, C Heymanslaan 10,1P1, Ghent, Belgium
[2] VIB Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium
[3] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium
[4] Ghent Univ Hosp, Dept Gen Internal Med, Ghent, Belgium
[5] Univ Ghent, Dept Internal Med & Pediat, HIV Cure Res Ctr, Ghent, Belgium
[6] Univ Ghent, Dept Biomol Med, Ghent, Belgium
关键词
D O I
10.1111/all.15101
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:304 / 307
页数:4
相关论文
共 50 条
  • [41] Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
    Parry, Helen
    Bruton, Rachel
    Stephens, Christine
    Brown, Kevin
    Amirthalingam, Gayatri
    Otter, Ashley
    Hallis, Bassam
    Zuo, Jianmin
    Moss, Paul
    IMMUNITY & AGEING, 2021, 18 (01)
  • [42] INFLIXIMAB IS ASSOCIATED WITH ATTENUATED IMMUNOGENICITY TO BNT162B2 AND CHADOX1 NCOV-19 SARS-COV-2 VACCINES
    Kennedy, Nicholas
    Lin, Simeng
    Goodhand, James
    Powell, Nicholas
    Ahmad, Tariq
    GUT, 2021, 70 : A3 - A4
  • [43] BNT162b2 COVID-19 vaccine
    不详
    AUSTRALIAN PRESCRIBER, 2021, 44 (02) : 57 - 58
  • [44] Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
    Favresse, Julien
    Gillot, Constant
    Di Chiaro, Laura
    Eucher, Christine
    Elsen, Marc
    Van Eeckhoudt, Sandrine
    David, Clara
    Morimont, Laure
    Dogne, Jean-Michel
    Douxfils, Jonathan
    VIRUSES-BASEL, 2021, 13 (07):
  • [45] Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia
    Ab Rahman, Norazida
    Lim, Ming Tsuey
    Lee, Fei Yee
    Jam, Emelyne Bani Anak
    Peariasamy, Kalaiarasu M.
    Sivasampu, Sheamini
    VACCINE: X, 2023, 14
  • [46] BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
    Behrens, Georg M. N.
    Barros-Martins, Joana
    Cossmann, Anne
    Ramos, Gema Morillas
    Stankov, Metodi, V
    Odak, Ivan
    Dopfer-Jablonka, Alexandra
    Hetzel, Laura
    Koehler, Miriam
    Patzer, Gwendolyn
    Binz, Christoph
    Ritter, Christiane
    Friedrichsen, Michaela
    Schultze-Florey, Christian
    Ravens, Inga
    Willenzon, Stefanie
    Bubke, Anja
    Ristenpart, Jasmin
    Janssen, Anika
    Ssebyatika, George
    Kraehling, Verena
    Bernhardt, Guenter
    Hoffmann, Markus
    Poehlmann, Stefan
    Krey, Thomas
    Bosnjak, Berislav
    Hammerschmidt, Swantje, I
    Foerster, Reinhold
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [47] Humoral and cellular responses to vaccination with homologous CoronaVac or ChAdOx1 and heterologous third dose with BNT162b2
    Hayashi, Jackelinne Y.
    Simizo, Adriana
    Miyamoto, Jackson G.
    Costa, Lucas V. S.
    Souza, Olivia F.
    Chiarelli, Tassia
    Bacarov, Natalia B. S.
    Hidalgo, Rafaela
    Garcia, Leticia D.
    Soane, Michel M.
    Braconi, Carla T.
    Maricato, Juliana T.
    Janini, Luiz M.
    Salomao, Reinaldo
    Popi, Ana F.
    Glezer, Isaias
    Bonetti, Tatiana
    Tashima, Alexandre K.
    JOURNAL OF INFECTION, 2022, 84 (06) : 866 - 868
  • [48] BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
    Georg M. N. Behrens
    Joana Barros-Martins
    Anne Cossmann
    Gema Morillas Ramos
    Metodi V. Stankov
    Ivan Odak
    Alexandra Dopfer-Jablonka
    Laura Hetzel
    Miriam Köhler
    Gwendolyn Patzer
    Christoph Binz
    Christiane Ritter
    Michaela Friedrichsen
    Christian Schultze-Florey
    Inga Ravens
    Stefanie Willenzon
    Anja Bubke
    Jasmin Ristenpart
    Anika Janssen
    George Ssebyatika
    Verena Krähling
    Günter Bernhardt
    Markus Hoffmann
    Stefan Pöhlmann
    Thomas Krey
    Berislav Bošnjak
    Swantje I. Hammerschmidt
    Reinhold Förster
    Nature Communications, 13
  • [49] Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
    Zhang, Chenyang
    Yin, Guosheng
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (19): : 1818 - 1819
  • [50] Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England
    Andrews, Nick J.
    Stowe, Julia
    Ramsay, Mary Eb
    Miller, Elizabeth
    LANCET REGIONAL HEALTH-EUROPE, 2022, 13